Corgenix Medical Corporation And Research Partners To Expand Ebola Virus Testing Capabilities In Sierra Leone
DENVER--(BUSINESS WIRE)--An outbreak of the deadly Ebola virus in West Africa has prompted Corgenix Medical Corporation (OTCBB:CONX) to extend its existing viral hemorrhagic fever (VHF) rapid test development to include the Ebola virus. Corgenix has already developed and CE marked a rapid test for the Lassa fever virus, another member of the VHF group of viruses.
Help employers find you! Check out all the jobs and post your resume.